Advancements in the control of genital human papillomavirus infections and related diseases: highlighting Australia's role.
Suzanne M
SM
Garland
Julia M L
JM
Brotherton
Christopher K
CK
Fairley
Dorota M
DM
Gertig
Marion
M
Saville
D001315:Australia; D017277:Drug Approval; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D015229:Sexually Transmitted Diseases, Viral / Q000517:prevention & control*; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18